Resveratrol: A New Anti-Coronavirus Drug
ISEF · 2016
Overview
Coronaviruses can cause fatal respiratory diseases in humans and are responsible for the most recent worldwide outbreak of the Middle East Respiratory Syndrome (MERS) that claimed more than 400 lives. However, no anti-coronavirus drug is currently available. In this study, resveratrol, a natural compound commonly found in some plants such as grapes, raspberries, and peanuts, was evaluated for any anti-coronavirus activity in an in-vitro cell culture system. In this system, when the cells are infected with a recombinant coronavirus that expresses a green fluorescence protein, virus infection and replication can be monitored in real time by observing the green fluorescence under a microscope. It was found that resveratrol completely blocked virus replication at a concentration of 25 µg/ml or higher. The 50% inhibitory concentration (IC50) was estimated to be 5.5 µg/ml. Importantly, when virus-infected cells were treated with resveratrol starting as late as 6 hours following infection, resveratrol still exhibited significant inhibitory effects on virus replication. These results demonstrate that resveratrol is potentially a potent anti-coronavirus drug that can be further developed for treatment of coronavirus-caused diseases.
Competition history
- ISEF 2016
Resources
Related projects
ISEF · 2021
Prophylactic and Therapeutic Roles of Glycyrrhiza glabra in the Prevention and Treatment of COVID19
ISEF · 2022
Investigating the Therapeutic Potential of Epigallocatechin Gallate and Theaflavin-3, 3'-digallate on Inhibiting ACE2-Spike Protein Binding and Mitigating Induced-Cellular Death by SARS-CoV-2
ISEF · 2014
Effects of Resveratrol on 5-Fluorouracil Chemotherapeutic DNA Damage and Drug Resistance in Breast and Prostate Cancer Cells
ISEF · 2021
Potential Treatment Targets for Covid-19: A Virtual Screening
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair